TET2/DNMT3A was co-mutated in human lung, breast, skin and kidney cancers and frequently in angioimmunoblastic and peripheral T cell lymphomas and several types of leukemia. Here, DNMT3A is linked to peripheral T-cell lymphoma, not otherwise specified.